Skip to main content
Premium Trial:

Request an Annual Quote

Bowel Disease Group Will Use Illumina s BeadChip for IBD Study

NEW YORK, Jan .12 (GenomeWeb News) - The NIDDK Inflammatory Bowel Disease Genetics Consortium will use the Sentrix HumanHap300 BeadChips and Infinium assay reagents for a genome-wide study, Illumina said today.

 

The consortium will genotype over 2,000 case-control samples to help identify genetic variants that increase susceptibility to Crohn's disease.

 

One thousand control individuals will be typed as part of the study, and the control genotypes will be made available to the scientific community.

 

The genotyping will be performed at The Feinstein Institute for Medical Research, part of the North Shore-Long Island Jewish Health System.

The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.